(Total Views: 688)
Posted On: 04/27/2020 12:56:26 PM
Post# of 72447
I saw the article on IL-6 in the link below on cytokines and Regeneron's drug...
https://endpts.com/covid-19-roundup-nih-remde...to-canada/
then when I looked at the updated information on B, I see it has potential to address many cytokines....:
"Brilacidin has been shown to inhibit IL-6, as well as other pro-inflammatory cytokines and chemokines (e.g., TNF-α, IL-1β, IL-6, IL-8, MIP2-α, MCP-1, MMP-9, and CINC-3), thereby positioning the drug as a promising intravenous treatment for COVID-19 patients. Given the redundancy of cytokine actions, targeting a single cytokine may have only limited effects on the complex inflammatory process."
https://endpts.com/covid-19-roundup-nih-remde...to-canada/
then when I looked at the updated information on B, I see it has potential to address many cytokines....:
"Brilacidin has been shown to inhibit IL-6, as well as other pro-inflammatory cytokines and chemokines (e.g., TNF-α, IL-1β, IL-6, IL-8, MIP2-α, MCP-1, MMP-9, and CINC-3), thereby positioning the drug as a promising intravenous treatment for COVID-19 patients. Given the redundancy of cytokine actions, targeting a single cytokine may have only limited effects on the complex inflammatory process."
(3)
(0)
